HEATHER ROSS: Open Payments
NPI 1255052502 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $67 |
| Philips North America LLC | 2 | $31 |
| Grifols USA, LLC | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
Products named: NUCALA, TRELEGY ELLIPTA, Vest Therapy Und, Prolastin-C Liquid, BREZTRI, JASCAYD, GLASSIA, NUZYRA.
Industry payments across KY — which companies pay providers there.
